Antimicrobial Agents Practice Questions

Q: Which of the following statements about clofazimine is incorrect?

Does not interfere with DNA synthesis. ***Does not interfere with DNA synthesis*** - Clofazimine's primary mechanism of action involves **DNA binding** and **interference with bacterial DNA synthesis**. - It also generates **reactive oxygen species** and disrupts membrane function, contributing to its bactericidal effect. - **This statement is INCORRECT** - clofazimine does interfere with DNA synthesis. *Used in lepra reaction* - Clofazimine is a crucial component in the treatment of **leprosy**, particularly effective in managing **Type 2 lepra reactions (erythema nodosum leprosum)** due to its anti-inflammatory effects. - It helps to reduce the severity and duration of these acute inflammatory episodes. *Used in treatment of leprosy* - Clofazimine is a **core component of multidrug therapy (MDT) for leprosy**, particularly in multibacillary leprosy. - It is recommended by the **WHO** as part of the standard treatment regimen for leprosy. *Causes ichthyosis and hyperpigmentation* - Clofazimine commonly causes **hyperpigmentation of the skin, conjunctiva, and bodily fluids**, often appearing reddish-brown to black. - Less commonly, it can also lead to **ichthyosis (dry, scaly skin)** as a side effect.

Q: An Englishman travels to a place which is resistant to chloroquine and mefloquine. What should he take as prophylaxis?

Atovaquone-proguanil. ***Atovaquone-proguanil*** - This combination, known as **Malarone**, is the most appropriate prophylactic agent for areas with **multi-drug resistant malaria**, including resistance to chloroquine and mefloquine [1], [2]. - It targets multiple stages of the parasite life cycle, providing excellent protection and is generally well-tolerated with specific **WHO and CDC recommendations** for chloroquine and mefloquine resistant areas [1], [3]. *Primaquine* - **Primaquine** is primarily used for **causal prophylaxis** against *P. vivax* and *P. ovale* to prevent relapse, not as primary prophylaxis [2]. - It is not typically recommended as the primary prophylactic agent in areas with **chloroquine and mefloquine resistance** and requires **G6PD testing** due to risk of hemolysis [1]. *Proguanil* - While proguanil is used for malaria prophylaxis, **proguanil alone** is not effective enough for prophylaxis in areas with multi-drug resistant malaria. - It is typically used in **combination with atovaquone** rather than as monotherapy for effective protection [3]. *Doxycycline* - **Doxycycline** is also an effective prophylactic agent for areas with **chloroquine and mefloquine-resistant malaria** and is commonly recommended [1], [2]. - While effective, it can cause **photosensitivity** and **gastrointestinal upset**, making atovaquone-proguanil the preferred first-line choice.

Q: Which drug is contraindicated in G6PD deficiency?

Primaquine. ***Primaquine*** - **Primaquine** is an antimalarial drug that generates **severe oxidative stress** in red blood cells. - It is **definitively contraindicated** in **G6PD deficiency** as it consistently causes **acute hemolytic anemia**. - Among antimalarials, primaquine poses the **highest risk** and should **never be used** in G6PD-deficient patients. - It is used for radical cure of P. vivax and P. ovale malaria, but alternative regimens must be used in G6PD deficiency. *Chloroquine* - **Chloroquine** can cause hemolysis in **G6PD deficiency**, though the risk is **lower than primaquine**. - It is **not considered fully safe** and should be used with **caution** in G6PD-deficient patients. - At standard doses, the risk is moderate, but hemolysis can occur, especially in certain G6PD variants. - However, it is not absolutely contraindicated and may be used when benefits outweigh risks with close monitoring. *Quinine* - **Quinine** can also cause **hemolysis** in patients with **G6PD deficiency**. - The risk varies with G6PD variant severity and dosage. - In **severe G6PD deficiency**, quinine should be avoided when alternatives are available. - While less consistently problematic than primaquine, it still requires caution and monitoring. *All of the options* - This option is incorrect in the context of this question because **primaquine** is the **most consistently and severely contraindicated** drug. - While chloroquine and quinine can cause hemolysis, they have **variable risk profiles** and may be used cautiously in some situations, unlike primaquine which is **absolutely contraindicated**. - The question asks for "which drug" (singular), indicating primaquine as the primary answer due to its consistent and severe risk.

Q: First generation cephalosporins are active against?

Gram positive bacteria. ***Gram positive bacteria*** - First-generation cephalosporins, such as **cefazolin** and **cephalexin**, primarily exhibit excellent activity against many **Gram-positive cocci**, including **staphylococci** and **streptococci**. - They are commonly used for skin and soft tissue infections and surgical prophylaxis due to this Gram-positive coverage. *Gram negative bacteria* - While first-generation cephalosporins have *some* activity against limited Gram-negative bacteria (e.g., *E. coli*, *Klebsiella pneumoniae*, *P. mirabilis*), their spectrum is generally weak and unreliable compared to later generations of cephalosporins. - They are not the drug of choice for serious Gram-negative infections. *Anaerobes* - First-generation cephalosporins have **poor activity** against most **anaerobic bacteria**. - For infections involving anaerobes, other antibiotics like **metronidazole**, **clindamycin**, or later-generation cephalosporins (e.g., cefoxitin, cefotetan) are generally preferred. *Dermatophytes* - Dermatophytes are **fungi** that cause skin, hair, and nail infections. - Cephalosporins are **antibacterial agents** and have **no activity** against fungi. Antifungal medications are required to treat dermatophyte infections.

Q: Which of the following is NOT an advantage of amoxicillin over ampicillin?

Spectrum includes H. influenzae & Shigella. ***Spectrum includes H. influenzae & Shigella*** - Amoxicillin and ampicillin both have a similar spectrum of activity against *Haemophilus influenzae* and *Shigella* species. Neither drug possesses a distinct advantage over the other in this regard for these specific pathogens. - Therefore, stating that amoxicillin's spectrum *includes* these bacteria as an advantage over ampicillin implies a unique characteristic, which is incorrect. *Better bioavailability & faster action* - **Amoxicillin** has superior oral **bioavailability** compared to ampicillin, leading to higher and more consistent blood levels. - This improved absorption often translates to a **faster onset of action** and allows for less frequent dosing. *Incidence of diarrhea is lower* - **Amoxicillin** is associated with a **lower incidence of diarrhea** and other gastrointestinal side effects compared to ampicillin. - This is partly due to its better absorption, meaning less unabsorbed drug reaches the colon to disrupt normal flora. *Food does not interfere with its absorption* - The absorption of **amoxicillin is largely unaffected by food**, allowing it to be taken without regard to meals. - In contrast, ampicillin's absorption can be significantly reduced when taken with food, making amoxicillin more convenient.

Q: What is the most serious side effect associated with Raltegravir?

Rhabdomyolysis. ***Rhabdomyolysis*** - Raltegravir, an **integrase strand transfer inhibitor (INSTI)**, can cause muscle-related side effects, including **rhabdomyolysis** and **myopathy**. [2] - Patients may present with muscle pain, weakness, and elevated **creatine kinase (CK)** levels. *Headache* - While headache can be a general side effect of many medications, it is not a **distinguishing or severe adverse effect commonly associated with Raltegravir** that would require specific monitoring. - Other more prominent side effects are typically prioritized in counseling and monitoring for this drug. *Hyperglycemia* - **Hyperglycemia** is not a commonly reported or significant side effect of Raltegravir. - While some antiretrovirals, particularly certain **protease inhibitors (PIs)** and **nucleoside reverse transcriptase inhibitors (NRTIs)**, are associated with altered glucose metabolism, INSTIs like Raltegravir generally have a more favorable metabolic profile. [1] *Hypertension* - Hypertension is generally **not a recognized or common side effect** of Raltegravir. - Cardiovascular events and hypertension are more frequently associated with other classes of antiretroviral drugs or as comorbidities in HIV-positive patients, rather than directly with INSTIs.

Q: What is the initial loading dose of chloroquine base for treating uncomplicated malaria in children?

10 mg/kg (maximum 600 mg). ***10 mg/kg (maximum 600 mg)*** - The standard **initial loading dose** of chloroquine base for uncomplicated malaria in children is **10 mg/kg body weight**, with a maximum cap of **600 mg** to prevent toxicity. - This is followed by **5 mg/kg** at 6 hours, 24 hours, and 48 hours (total course of 25 mg/kg over 3 days). - This represents **WHO-recommended** weight-based dosing for pediatric malaria treatment. *5 mg/kg* - **5 mg/kg** is the dose for the **subsequent doses** (at 6, 24, and 48 hours after the initial dose), not the initial loading dose. - The initial dose must be higher (10 mg/kg) to rapidly achieve therapeutic blood levels. *15 mg/kg* - **15 mg/kg** exceeds the recommended initial dose and increases the risk of **chloroquine toxicity**. - Chloroquine has a narrow therapeutic index, and overdosing can cause serious **cardiovascular** (arrhythmias, hypotension) and **neurological** effects (seizures, visual disturbances). *25 mg/kg* - **25 mg/kg** represents the **total cumulative dose** over the entire 3-day treatment course, not the initial single dose. - Giving this amount as a single dose would result in severe toxicity and is contraindicated.

Q: What is the drug of choice for malaria in pregnancy?

Chloroquine. ***Chloroquine*** - **Chloroquine** is the drug of choice for **uncomplicated malaria in pregnancy** caused by **chloroquine-sensitive** strains of *P. vivax*, *P. ovale*, *P. malariae*, and *P. falciparum* [1]. - It has an **established safety profile** in pregnancy across all trimesters and is considered safe by WHO and CDC. - While resistance has emerged in many areas for *P. falciparum*, chloroquine remains effective for *P. vivax* malaria in most regions including India. - For **severe malaria** or **chloroquine-resistant falciparum malaria**, alternative regimens like quinine or artesunate are used [1]. *Quinine* - **Quinine** (usually with clindamycin) is the preferred treatment for **severe malaria** or **chloroquine-resistant *P. falciparum*** malaria in pregnancy, especially in the **first trimester**. - It is safe and effective but can cause side effects like **cinchonism** (tinnitus, headache, nausea) and **hypoglycemia**. - While safe throughout pregnancy, it is not the first-line choice for uncomplicated chloroquine-sensitive malaria. *Primaquine* - **Primaquine** is **contraindicated in pregnancy** because it can cause **hemolytic anemia** in individuals with **G6PD deficiency**, and G6PD status of the fetus cannot be determined [3]. - It is used for **radical cure** of *P. vivax* and *P. ovale* to eliminate liver hypnozoites, but must be deferred until after delivery [3]. *Artesunate* - **Artesunate** and other **artemisinin-based combination therapies (ACTs)** are highly effective antimalarials [2]. - Current WHO guidelines support ACT use in all trimesters for severe malaria when benefits outweigh risks. - For **uncomplicated falciparum malaria**, ACTs are preferred in the **second and third trimesters** in areas with chloroquine resistance [2]. - However, chloroquine remains the classical "drug of choice" for uncomplicated, chloroquine-sensitive malaria in pregnancy [1].

Q: Which of the following medications is not typically used in the treatment of malignant malaria?

Quinolone. ***Quinolone*** - **Quinolone** antibiotics, while broad-spectrum, are not typically used as primary antimalarial agents due to limited efficacy against *Plasmodium falciparum* and potential for resistance. - Their use in malaria treatment is generally restricted to specific co-infections rather than direct antimalarial efficacy. *Quinine* - **Quinine** has been a cornerstone of severe malaria treatment for many years, especially in regions with limited access to newer artemisinin derivatives. - It works by interfering with the parasite's ability to detoxify heme, thus killing the parasites. *Doxycycline* - **Doxycycline** is an effective antimalarial, particularly as a prophylactic agent and in combination therapy for uncomplicated malaria or as an alternative for severe malaria when other agents are contraindicated. - It inhibits **protein synthesis** in the parasite. *Artesunate* - **Artesunate** is the recommended first-line treatment for severe malaria due to its rapid action and potent parasiticidal effects. - It is an **artemisinin derivative** that produces free radicals toxic to the parasite.

Q: Drug of choice for Pneumocystis jirovecii in pregnancy?

Trimethoprim-sulfamethoxazole (SMZ/TMP). ***Trimethoprim-sulfamethoxazole (SMZ/TMP)*** - Despite being a **folate antagonist**, SMZ/TMP is considered safe and the **drug of choice** for treating **Pneumocystis jirovecii pneumonia (PJP)** in pregnant women, particularly as the benefits outweigh the risks. - It is recommended to supplement with **folic acid** during treatment to mitigate potential teratogenic risks, although these risks are generally low. *Primaquine* - **Primaquine** is primarily used for the treatment of **Plasmodium vivax** and **Plasmodium ovale malaria**, specifically targeting hypnozoites in the liver. - It is contraindicated in pregnancy due to the risk of **hemolytic anemia** in the fetus, especially if the fetus has **glucose-6-phosphate dehydrogenase (G6PD) deficiency**. *Dapsone* - **Dapsone** is used in the treatment of **leprosy**, **dermatitis herpetiformis**, and as an alternative for **PJP prophylaxis** in HIV-positive patients. - While it can be used for PJP prophylaxis, its efficacy for **active PJP treatment** is lower than SMZ/TMP, and it carries risks of **hemolytic anemia** and **methemoglobinemia**, particularly in pregnancy. *Pentamidine* - **Pentamidine** is an alternative treatment for **PJP**, especially in patients who cannot tolerate SMZ/TMP. - It is typically reserved for **severe cases** or as a second-line agent due to its potential for **significant toxicity**, including hypotension, nephrotoxicity, and hypoglycemia, which can be particularly concerning in pregnancy.

Question 1

Which of the following statements about clofazimine is incorrect?

Accepted Answer

Does not interfere with DNA synthesis

Answer

Used in lepra reaction

Answer

Used in treatment of leprosy

Answer

Causes ichthyosis and hyperpigmentation

Question 2

An Englishman travels to a place which is resistant to chloroquine and mefloquine. What should he take as prophylaxis?

Accepted Answer

Atovaquone-proguanil

Answer

Primaquine

Answer

Doxycycline

Answer

Proguanil

Question 3

Which drug is contraindicated in G6PD deficiency?

Accepted Answer

Primaquine

Answer

Chloroquine

Answer

Quinine

Answer

All of the options

Question 4

First generation cephalosporins are active against?

Accepted Answer

Gram positive bacteria

Answer

Gram negative bacteria

Answer

Anaerobes

Answer

Dermatophytes

Question 5

Which of the following is NOT an advantage of amoxicillin over ampicillin?

Accepted Answer

Spectrum includes H. influenzae & Shigella

Answer

Incidence of diarrhea is lower

Answer

Food does not interfere with its absorption

Answer

Better bioavailability & faster action

Question 6

What is the most serious side effect associated with Raltegravir?

Accepted Answer

Rhabdomyolysis

Answer

Hyperglycemia

Answer

Hypertension

Answer

Headache

Question 7

What is the initial loading dose of chloroquine base for treating uncomplicated malaria in children?

Accepted Answer

10 mg/kg (maximum 600 mg)

Answer

5 mg/kg

Answer

15 mg/kg

Answer

25 mg/kg

Question 8

What is the drug of choice for malaria in pregnancy?

Accepted Answer

Chloroquine

Answer

Primaquine

Answer

Artesunate

Answer

Quinine

Question 9

Which of the following medications is not typically used in the treatment of malignant malaria?

Accepted Answer

Quinolone

Answer

Doxycycline

Answer

Artesunate

Answer

Quinine

Question 10

Drug of choice for Pneumocystis jirovecii in pregnancy?

Accepted Answer

Trimethoprim-sulfamethoxazole (SMZ/TMP)

Answer

Primaquine

Answer

Dapsone

Answer

Pentamidine

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?